Behzad Baradaran
- Molecular Biology top 5%
- Biomedical Engineering top 5%
- Oncology top 5%
- Cancer Research top 2%
- Immunology top 5%
- Co-authors
- Ahad MokhtarzadehFatemeh OroojalianMohammad‐Ali ShahbaziM H Miran BeygiMohammad AminiNicola SilvestrisMahdi Abdoli ShadbadBehzad Mansoori
- Topics
- MicroRNA in disease regulation (33 papers)Cancer Immunotherapy and Biomarkers (21 papers)Circular RNAs in diseases (21 papers)
- Cited by
- Cancer ResearchImmunologyOncology
- Journals
- SHILAP Revista de lepidopterologíaScientific ReportsJournal of Controlled Release
In The Last Decade
Behzad Baradaran
108 papers receiving 2.8k citations
Hit Papers
Peers
Comparison fields: 5 of 122
- Molecular Biology 1.4k
- Biomedical Engineering 773
- Oncology 757
- Cancer Research 664
- Immunology 659
Countries citing papers authored by Behzad Baradaran
This map shows the geographic impact of Behzad Baradaran's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Behzad Baradaran with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Behzad Baradaran more than expected).
Fields of papers citing papers by Behzad Baradaran
This network shows the impact of papers produced by Behzad Baradaran. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Behzad Baradaran. The network helps show where Behzad Baradaran may publish in the future.
Co-authorship network of co-authors of Behzad Baradaran
This figure shows the co-authorship network connecting the top 25 collaborators of Behzad Baradaran. A scholar is included among the top collaborators of Behzad Baradaran based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Behzad Baradaran. Behzad Baradaran is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 2 | |
| 2 | 0 | |
| 3 | 0 | |
| 4 | 2 | |
| 5 | 17 | |
| 6 | 64 | |
| 7 | 7 | |
| 8 | 9 | |
| 9 | 13 | |
| 10 | 1 | |
| 11 | Effects of PEI-PEG Nanoparticles Loaded With CD44 siRNA on Inhibition of Growth, Invasion, and Migration of Glioblastoma Cells | 2 |
| 12 | 26 | |
| 13 | 14 | |
| 14 | 67 | |
| 15 | 35 | |
| 16 | 7 | |
| 17 | 53 | |
| 18 | 0 | |
| 19 | 12 | |
| 20 | 30 |
About Behzad Baradaran
Behzad Baradaran is a scholar working on Cancer Research, Oncology and Immunology, having authored 113 papers that have together received 2.9k indexed citations. Recurring topics across this work include MicroRNA in disease regulation (33 papers), Cancer Immunotherapy and Biomarkers (21 papers) and Circular RNAs in diseases (21 papers). The work is most often cited by research in Cancer Research (664 citations), Immunology (659 citations) and Oncology (757 citations). Behzad Baradaran has collaborated with scholars based in Iran, Italy and Denmark. Frequent co-authors include Ahad Mokhtarzadeh, Fatemeh Oroojalian, Mohammad‐Ali Shahbazi, M H Miran Beygi, Mohammad Amini, Nicola Silvestris, Mahdi Abdoli Shadbad, Behzad Mansoori, Ali Mohammadi and Oronzo Brunetti. Their work appears in journals such as SHILAP Revista de lepidopterología, Scientific Reports and Journal of Controlled Release.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.